General information
JACARDI was created as the European Union's concrete response to the growing incidence of cardiovascular disease and diabetes, two of the main causes of mortality and morbidity on the continent. The project is part of the EU4Health programme to support Member States in strengthening their health systems through evidence-based interventions.
JACARDI is distinguished by its systemic and multilevel approach. The initiative not only analyses health issues, but aims at the concrete transformation of prevention, diagnosis, treatment and social inclusion pathways, with a focus on the social determinants of health and the reduction of inequalities between European territories.
A central element of the project are 142 pilot interventions, adapted to different national and local contexts, which will make it possible to test and evaluate innovative, replicable and sustainable solutions over time. These interventions cover the entire life cycle of diseases, fosteringcoordinated action between health professionals, public authorities, local communities and citizens.
With a strong component of governance, peer exchange and capacity building, JACARDI promotes a culture of inter-institutional and transnational cooperation, strengthening the resilience of European health systems in the long run. Furthermore, the project will contribute to the creation of a shared heritage of knowledge, tools and data at the service of public policies.
JACARDI involves 21 EU countries and 77 partners. Italy coordinates the entire joint action through the Istituto Superiore di Sanità (ISS), contributing significantly to the strategic planning, management and dissemination of results. Several Italian institutions, including the Autonomous Province of Trento, actively participate as affiliated bodies in the implementation of the pilot projects and in the development of related health policies.
Goals
- Improve health literacy and raise awareness about CVD and DM in the general population.
- Implement effective primary prevention measures, screening and improved care pathways for high-risk groups.
- Enhance self-management support and labour market participation for people diagnosed with CVD and DM.
- Improve the availability, quality and accessibility of data along the entire patient pathway.
Milestones
- November 2023: Project start-up
- 2024: Preparation and planning of pilot projects.
- 2025-2026: Pilot project implementation and data collection.
- 2027: Analysis of results, impact assessment and development of sustainability strategies.
Work Packages
The activities are distributed in 11 work packages (WP) of which 5 are transversal, with an innovative WP on the development of a common methodological framework and an integrative approach, and 6 are technical:
- WP1 - Management and coordination - Ensures effective project management and communication between partners.
- WP2 - Communication and Dissemination - Promotes the visibility of the project and the dissemination of results.
- WP3 - Evaluation - Monitors the implementation and assesses the impact of activities.
- WP4 - Sustainability of Results - Develops strategies to ensure the long-term adoption of good practices.
- WP5 - National governance and quality assurance models - Supports the development of national governance and quality models.
- WP6 - Health literacy and awareness - Improves understanding of CVD and DM among the population.
- WP7 - Data availability, quality, accessibility and sharing - Strengthens data collection and analysis to support policy decisions.
- WP8 - Screening of high-risk populations - Implements screening programmes to identify at-risk individuals early.
- WP9 - Integrated care pathways - Develops and promotes integrated care models for CVD and DM.
- WP10 - Patient self-management - Supports patients in self-management of their conditions.
- WP11 - Labour participation of people with CVD or DM - Promotes labour inclusion of people with these diseases.
Start date
01/11/2023
End date
31/10/2027